Fresenius SE & Co. KGaA said Tuesday that net profit and sales both rose in the third quarter, and backed its full-year outlook.
Net income was 444 million euros ($492.4 million), up from EUR419 million in the previous-year period, while sales grew 7.9% to EUR8.42 billion.
The German provider of health products and services FRE, +2.30% backed its earnings guidance for 2019. The company sees sales growth at constant currency rates of between 4% to 7%, while net income on a comparable basis is expected to be flat.
At Fresenius Medical Care (FME.XE), the company’s dialysis division, net profit rose 17% to EUR333 million, while sales increased by 8.9% to EUR4.42 billion.